Novartis Investigative Site

Mizunami, Gifu 509-6134

0 studies enrolling now · 5 studies all time

What they study most

Asthma, Pulmonary Disease, Chronic Obstructive, Sarcopenia

Studies at this site

• Dose-range Finding Efficacy and Safety Study for QBW251 in COPD Patients — Completed
• Dose Range Finding Study of Bimagrumab in Sarcopenia — Completed
• Dose Finding Study for QAW039 in Asthma — Completed
• Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment — Stopped early
• A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study — Completed